Foraviset Ltd. ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Foraviset is a women's health-focused biopharmaceutical company developing non-hormonal therapies for uterine disorders, including endometriosis.

Biotechnology
Active
Jerusalem, Israel Founded 2018
Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2018
Headcount
—
HQ
Jerusalem, Israel
Sector
Biotechnology

About

Foraviset is a women's health-focused biopharmaceutical company dedicated to transforming women's health by developing non-hormonal therapies for uterine disorders, particularly endometriosis. The company is pioneering Raviset®, a first-in-class, non-hormonal, non-surgical therapy that targets the root cause of inflammation through the inducible Nitric Oxide Synthase (iNOS) pathway. With over two decades of research, compelling clinical outcomes, and a robust IP portfolio, Raviset® aims to deliver safe, effective, and fertility-compatible relief. Foraviset is currently preparing for a Phase IIa clinical trial for Raviset® in endometriosis.

Funding history · 1 round · — total

1 event/round · — Total Funding
Aug 2026
A Round Undisclosed nogafem-womens-health.org ↗

Offices

Jerusalem, Israel · HQ / main office

Q&A

What is Foraviset Ltd.'s primary focus?
Foraviset Ltd. is a women's health-focused biopharmaceutical company developing non-hormonal therapies for uterine disorders, particularly endometriosis.
When was Foraviset Ltd. founded?
Foraviset Ltd. was founded in 2018.
What is the name of Foraviset Ltd.'s lead product candidate?
Foraviset Ltd. is pioneering Raviset®, a first-in-class, non-hormonal, non-surgical therapy.
What is the mechanism of action for Raviset®?
Raviset® targets the root cause of inflammation through the inducible Nitric Oxide Synthase (iNOS) pathway.
What is the current clinical trial stage for Raviset®?
Foraviset Ltd. is currently preparing for a Phase IIa clinical trial for Raviset® in endometriosis.
Who is the CEO and Co-Founder of Foraviset Ltd.?
Jacob Marx is the CEO & Co-Founder of Foraviset Ltd., appointed in August 2018.
What is Foraviset Ltd.'s primary sector?
Foraviset Ltd.'s primary sector is Biotechnology.
Has Foraviset Ltd. raised any funding rounds?
Yes, Foraviset Ltd. completed an A Round in August 2026.

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteforaviset.com

Identifiers & details

Legal nameFORAVISET LTD
Founded2018

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domainforaviset.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515893717
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2018-08-23
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens1
Registry events7 — other (1), shares_capital (2), charge (1), people (3)
Registered addressקרן היסוד 19 ירושלים

Recent registry events

DateEvent
2026-08-23עדכון כתובת ו/או מען דיגיטלי
2026-04-23העברת מניות
2026-04-23רישום שעבוד
2026-02-17עדכון דירקטורים-הוספת דירקטור
2026-02-17עדכון דירקטורים-הסרת דירקטור
2026-02-17הקצאת מניות
2026-02-17עדכון בעלי תפקידים